Literature DB >> 8083349

Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals.

B J Morris1, R Y Zee, A P Schrader.   

Abstract

The frequency of the D allele of an insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene has been reported to be elevated in myocardial infarction and other patients. We therefore hypothesized that death rate of DD individuals should be increased in the population as a whole and this should be evident as a decrease in DD frequency with age. This hypothesis was tested in 118 Caucasian subjects who were already at high risk of cardiovascular events by having severe, early onset, familial hypertension (HT). A group of 196 age-, sex- and body mass index-matched normotensives (NTs) was used as a control. In the NT group II, ID, and DD genotype frequencies were similar for different age groups. DD frequency was 0.42 in NTs, but in HTs was 0.28, 0.26, and 0.10 for the age groups < 50, 50-59, and > or = 60 yr, respectively. Corresponding D allele frequencies were 0.52, 0.46, and 0.40 in the respective age groups of HTs, compared with 0.61 in NTs (by chi 2-analysis, P = 0.1, 0.047, and 0.0006, respectively). In HTs aged > or = 60, DD frequency was only 14% of expected. Plasma ACE activity tracked similarly with I/D genotype in HTs (P = 0.027; n = 35) as in NTs (P = 0.0001; n = 94) and Michaelis constant was identical for DD and II. Neither blood pressure, body mass index, nor sex bore any relationship with I/D genotype. In conclusion, in a group of severely HT patients not selected for cardiac pathology, there appeared to be a marked, selective decrease, in subgroups of increasing age, in frequency of the ACE DD genotype. One possibility suggested by this data might be that DD increases risk of premature death, at least in HTs who have two HT parents.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083349      PMCID: PMC295169          DOI: 10.1172/JCI117423

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

Review 1.  Angiotensin-converting enzyme: new concepts concerning its biological role.

Authors:  M R Ehlers; J F Riordan
Journal:  Biochemistry       Date:  1989-06-27       Impact factor: 3.162

2.  Association and linkage analyses of restriction fragment length polymorphisms for the human renin and antithrombin III genes in essential hypertension.

Authors:  R Y Zee; L H Ying; B J Morris; L R Griffiths
Journal:  J Hypertens       Date:  1991-09       Impact factor: 4.844

3.  Association of a RFLP for the insulin receptor gene, but not insulin, with essential hypertension.

Authors:  L H Ying; R Y Zee; L R Griffiths; B J Morris
Journal:  Biochem Biophys Res Commun       Date:  1991-11-27       Impact factor: 3.575

4.  Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.

Authors:  F Cambien; F Alhenc-Gelas; B Herbeth; J L Andre; R Rakotovao; M F Gonzales; J Allegrini; C Bloch
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

5.  Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene.

Authors:  C Hubert; A M Houot; P Corvol; F Soubrier
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

6.  Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension.

Authors:  R Y Zee; Y K Lou; L R Griffiths; B J Morris
Journal:  Biochem Biophys Res Commun       Date:  1992-04-15       Impact factor: 3.575

7.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

8.  Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.

Authors:  L Tiret; B Rigat; S Visvikis; C Breda; P Corvol; F Cambien; F Soubrier
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

9.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Authors:  B Rigat; C Hubert; F Alhenc-Gelas; F Cambien; P Corvol; F Soubrier
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

10.  Neuropeptide-Y Y1 receptor gene polymorphism: cross-sectional analyses in essential hypertension and obesity.

Authors:  H Herzog; L A Selbie; R Y Zee; B J Morris; J Shine
Journal:  Biochem Biophys Res Commun       Date:  1993-10-29       Impact factor: 3.575

View more
  13 in total

Review 1.  Genetic and epigenetic regulation of human aging and longevity.

Authors:  Brian J Morris; Bradley J Willcox; Timothy A Donlon
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-01       Impact factor: 5.187

2.  Different antioxidants status, total antioxidant power and free radicals in essential hypertension.

Authors:  Manoj K Kashyap; Vibha Yadav; Badan S Sherawat; Sanjay Jain; Savita Kumari; Madhu Khullar; Prakash C Sharma; Ravinder Nath
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

3.  ACE2 gene polymorphism and essential hypertension: an updated meta-analysis involving 11,051 subjects.

Authors:  Na Lu; Yang Yang; Yibo Wang; Yan Liu; Gang Fu; Dongmei Chen; Hui Dai; Xiaohan Fan; Rutai Hui; Yang Zheng
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

4.  Age differences in arterial and venous extra-cerebral blood flow in healthy adults: contributions of vascular risk factors and genetic variants.

Authors:  Naftali Raz; Ana M Daugherty; Sean K Sethi; Muzamil Arshad; E Mark Haacke
Journal:  Brain Struct Funct       Date:  2017-01-24       Impact factor: 3.270

5.  The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes.

Authors:  M K Bulsara; C D J Holman; F M van Bockxmeer; E A Davis; P H Gallego; J P Beilby; L J Palmer; C Choong; T W Jones
Journal:  Diabetologia       Date:  2007-02-27       Impact factor: 10.122

6.  Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy.

Authors:  L Tarnow; F Cambien; P Rossing; F S Nielsen; B V Hansen; L Lecerf; O Poirier; S Danilov; S Boelskifte; K Borch-Johnsen
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

7.  Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study.

Authors:  David Conen; Robert J Glynn; Julie E Buring; Paul M Ridker; Robert Y L Zee
Journal:  J Hypertens       Date:  2008-09       Impact factor: 4.844

8.  Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia.

Authors:  H K Wang; H C Fung; W C Hsu; Y R Wu; J C Lin; L S Ro; K H Chang; F J Hwu; Y Hsu; S Y Huang; G J Lee-Chen; C M Chen
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

9.  Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats.

Authors:  R Kreutz; M S Fernandez-Alfonso; Y Liu; D Ganten; M Paul
Journal:  J Mol Med (Berl)       Date:  1995-05       Impact factor: 4.599

10.  Effects of age, genes, and pulse pressure on executive functions in healthy adults.

Authors:  Naftali Raz; Cheryl L Dahle; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neurobiol Aging       Date:  2009-06-25       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.